Drug Database
Back to search

Poland· PL-100479940

Nintedanib Accordpharma

A nintedanib product containing nintedanibum, registered in Poland by Accord Healthcare Polska Sp. z o.o.. The same ATC class is registered in 14 of our 19 countries.

ATC L01EX09

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedNintedanib AccordpharmaATCL01EX09REGISTER NO.PL-100479940PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about nintedanibumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nintedanib is registered in 14 of 19 countries.

Countries holding a registration under ATC L01EX09 (nintedanib), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search nintedanib products by name

Nintedanib · ATC L01EX09

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of nintedanib costs, country by country.

Normalised to the WHO defined daily dose (0.38 g), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Nintedanib · price per daily dose (0.38 g)

USD · FX 28 Sept 2026

  • US United States$51.13 (acquisition cost)
  • CH Switzerland$34.12
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Nintedanibum
Manufacturer
Accord Healthcare Polska Sp. z o.o.
Country
Poland (PL)
ATC code
L01EX09
ATC class
Nintedanib
Defined daily dose
0.38 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909991570156
  • gtin
    05909991570163
  • gtin
    05909991570170
  • gtin
    05909991570187

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

160 interactions on record for nintedanib.

Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check nintedanib against other medicinesHow interaction checks work

Nintedanib · interactions on record

160 records

  • 21 severe
  • 139 moderate

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • DexamethasoneH02AB02severe
  • RifampicinJ04AB02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nintedanib in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nintedanib products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Nintedanib Cipla, Nintedanib Ratiopharm
  • Belgium · Nintedanib Accordpharma, Nintedanib Eg
  • Cyprus · Nintedanib Teva
  • Czechia · Nintedanib Glenmark, Nintedanib Sandoz
  • Germany · Nintedanib, Nintedanib 1 A Pharma
  • Denmark · Nintedanib "sandoz", Nintedanib Glenmark
  • Estonia · Agarf, Nintedanib Sandoz
  • Spain · Nintedanib, Nintedanib Accordpharma
  • Finland · Nintedanib Glenmark, Nintedanib Ratiopharm
  • France · Nintedanib Arrow, Nintedanib Biogaran
  • United Kingdom (Northern Ireland) · Nintedanib, Nintedanib Accord Healthcare
  • Greece · Nifib, Nindraf
  • Croatia · Gevesla, Nintedanib Accordpharma
  • Hungary · Nintedanib Accordpharma, Nintedanib Onkogen
  • Ireland · Nintedanib Accordpharma, Nintedanib Clonmel
  • Iceland · Agarf, Nintedanib Accord
  • Italy · Nintedanib Accordpharma, Nintedanib Aurobindo
  • Liechtenstein · Nintedanib Accord, Nintedanib Viatris
  • Lithuania · Agarf, Nintedanib Sandoz
  • Luxembourg · Nintedanib Eg, Nintedanib Eurogenerics
  • Latvia · Agarf, Nintedanib Sandoz
  • Malta · Nifiden Adalvo, Nintedanib Adalvo
  • Netherlands · Gevesla, Nintedanair
  • Norway · Nintedanib Accord, Nintedanib Devatis
  • Portugal · Nintedanib Accordpharma, Nintedanib Eugia
  • Romania · Gevesla, Nintedanib Dr. Reddy’s
  • Sweden · Nintedanib Devatis, Nintedanib Glenmark
  • Slovenia · Nintedanib Accordpharma, Nintedanib Stada
  • Slovakia · Nintedanib Stada, Nintedanib Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/150babe6-a72a-49e2-97c8-7adee53d03f2
GET /v1/drugs/150babe6-a72a-49e2-97c8-7adee53d03f2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki miękkie",
  "source": "urpl",
  "strength": "150 mg",
  "packaging": "05909991570156 ¦ Rpz ¦ 161391\n60 kaps. w blistrze\n05909991570163 ¦ Rpz ¦ 161392\n120 kaps. w blistrze\n05909991570170 ¦ Rpz ¦ 161393\n60 kaps. w blistrze perforowanym\n05909991570187 ¦ Rpz ¦ 161394\n120 kaps. w blistrze perforowanym",
  "substance": "Nintedanibum 150 mg",
  "common_name": "Nintedanibum",
  "pl_product_id": "100479940",
  "pozwolenie_nr": "28966",
  "auth_procedure": "DCP",
  "authorisation_validity": "2030-03-31"
}
API referenceMCP serverPlans

See everything about nintedanib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console